Colleen Halfpenny
BASICS
DESCRIPTION
Benign conjunctival lesions are a group of tumors, including papilloma (Pap), Kaposi’s sarcoma (KS), limbal dermoid (LD), sarcoidosis (Sarc), and pyogenic granuloma (PG) with a low potential for malignant growth and a wide variety of etiologies and management considerations.
EPIDEMIOLOGY
Incidence
• Systemic KS: 4–14% in ocular adnexa (1)[C]
• Ocular KS: 7–18%
• Ocular Sarc: 7–19%
RISK FACTORS
• Pap: Mother with positive human papillomavirus (HPV) history, UV radiation
• KS: Immunocompromised states, including HIV/AIDS, chemotherapy, organ transplantation, elderly males
• LD: <18 years of age
• Sarc: African American race
• PG: transconjunctival surgical incisions (strabismus, retinal surgery), trauma (2)[B]
Genetics
Sarc: HLA-Bw15, HLA-B8, HLA-B13
PATHOPHYSIOLOGY
• Pap: HPV, a double-stranded DNA virus transmitted via direct contact, often through passage of infected birth canal leading to proliferation of fibrovascular connective tissue, acanthosis, and hyperkeratosis
• KS: Dysregulated inflammatory cytokine response due to human herpesvirus-8
• LD: Congenital choristomatous changes due to an unknown process; classified based upon the extent of anterior segment involvement
• Sarc: Inflammatory hyperactivity due to dysregulated cytokine responses following an antigenic stimulus
• PG: Proliferative fibrovascular and inflammatory response usually secondary to aberrant wound healing
ETIOLOGY
• Pap: HPV, most commonly benign types 6 and 11, rarely type 16 or 45
• KS: Human herpesvirus-8 (HHV-8) DNA or Kaposi’s sarcoma-associated herpesvirus (KSHV), implicated with patients who are HIV-negative and HIV-positive
• Sarc: Unknown etiology. Suggested causes: Environmental toxins, infectious agents, genetic transmission
• LD: Unknown
• PG: Usually due to prior inflammatory condition or status post trauma or surgery
COMMONLY ASSOCIATED CONDITIONS
• LD: Goldenhar’s syndrome
• Sarc: Mikulicz’s syndrome: Salivary and lacrimal gland enlargement with keratoconjunctivitis sicca
DIAGNOSIS
HISTORY
• Pap, KS, LD, Sarc, PG:
– often asymptomatic
– mass effect symptoms
– foreign body sensation
– itching
– tearing
– mucous
– ptosis
– photophobia
– blurry vision
– swelling
– trichiasis
– poor lid apposition
– cosmetic effects
• KS: Immune status
• Sarc: Lung and skin nodules, dyspnea, cough malaise, fatigue, lymphadenopathy
• LD: <18 years of age, enlarging since birth, especially after puberty
• PG: History of surgery, inflammatory condition
PHYSICAL EXAM
• Pap: Pedunculated or sessile, pink-red, fleshy, smooth often verrucous appearing on bulbar or palpebral conjunctiva. Viral usually multiple lesions in inferior fornix; single lesions may suggest nonviral etiology and may extend toward the limbus.
• KS: Flat or raised, reddish-purple, oval, nontender mass, or nodular, well-circumscribed lesion
• Sarc: Single or multiple, yellow or salmon colored nodules. Most commonly on palpebral conjunctiva of lower cul-de-sac or plica semilunaris
• LD: Yellowish-white oval-shaped, solid mass involving bulbar conjunctiva, typically near the inferotemporal corneoscleral limbus; may have fine hairs
• PG: well-vascularized, elevated, red-fleshy mass with fibrous stalk
• Secondary findings for all of the above include chemosis, mechanical ectropion, superficial punctuate keratopathy, and corneal dellen.
DIAGNOSTIC TESTS & INTERPRETATION
Lab
• KS: HIV ELISA, HIV Western Blot, CD4
• Sarc: Angiotensin-converting enzyme, calcium, magnesium, phosphorous
Imaging
Sarc: Chest X-ray
Diagnostic Procedures/Other
• Slit lamp, dilated fundus examination, tonometry
• Pap, KS, Sarc, PG: incisional or excisional biopsy, if suspicious for malignancy
• LD: Depth of corneal involvement can be evaluated with ultrasound biomicroscopy (UBM). Examine patient for signs and symptoms of Goldenhar’s syndrome, including preauricular skin appendages, hearing loss, lid coloboma, and naso-oro-vertebral anomalies (4)[C].
Pathological Findings
• Pap: Multiple branching fronds with a fibrovascular core lined by thickened, acanthotic, squamous epithelium with or without koilocytosis
• KS: Thin, dilated, endothelial-lined vascular channels surrounded by spindle cells and inflammatory reaction
• LD: Conjunctival epithelium with epidermal appendages surrounding simple choristomatous tissue including hair follicles, sebaceous glands, muscle, adipose, teeth, bone, and cartilage
• Sarc: Noncaseating granulomas
• PG: Granulation tissue, chronic inflammation, small blood vessels
DIFFERENTIAL DIAGNOSIS
• Pap: Conjunctival intraepithelial neoplasia, squamous cell carcinoma, amelanotic melanoma, lymphoma
• KS: Subconjunctival hemorrhage, hemangiopericytoma, pyogenic granuloma, capillary and cavernous hemangioma, lymphoma, malignant melanoma, pingueculitis, bacillary angiomatosis
• Sarc: Chalazia, pyogenic granuloma, conjunctival intraepithelial neoplasia, mycobacterial infections, fungal infection, foreign body granuloma, papilloma
• DL: Pterygium, pinguecula, juvenile xanthogranuloma, staphyloma, foreign body reaction, sclerocornea
• PG: Foreign body granuloma, chalazion, sarcoidosis, papilloma, lymphoma
TREATMENT
MEDICATION
First Line
• Pap: Observation for spontaneous resolution
• LD: Topical lubrication, removal of irritating hairs
• KS: Highly active antiretroviral therapy (HAART) (1)[B]
• Sarc: Topical steroid
• PG: Observation for spontaneous resolution
Second Line
• Pap: Topical interferon-alpha-2b, mitomycin C, oral cimetidine (3)[C]
• KS: Local chemotherapy (vinblastine and vincristine), low dose radiotherapy, topical interferon-alpha, human choriogonadotropin
• PG: Low-dose plaque radiotherapy for recurrent PG (4)[C]
ADDITIONAL TREATMENT
Issues for Referral
LD: If clinically suspicious for Goldenhar’s syndrome, consult pediatrician with genetics specialty
SURGERY/OTHER PROCEDURES
• Pap: Excisional biopsy with or without cryotherapy if symptomatic, or if concern for malignancy
• KS: Surgical excision, if refractory to HAART, with 1–2 mm margins
• LD: Superficial sclerokeratectomy with or without lamellar graft
• Sarc: Surgical excision, if symptomatic
• PG: Surgical excision, if symptomatic
ONGOING CARE
FOLLOW-UP RECOMMENDATIONS
• Outpatient care for periodic observation of lesions and surgical excision of benign conjunctival masses
• Inpatient care for systemic management of complicating illness
PROGNOSIS
Highly favorable prognosis
COMPLICATIONS
• Lesions may reoccur after excision
• Secondary to surgical excision, including scaring, infection, bleeding, blindness
• LD: Refractive error; cornea may remain opacified from scar after surgery
• Systemic complications of underlying conditions
REFERENCES
1. Curtis TH, Durairaj VD. Conjunctival Kaposi sarcoma as the initial presentation of human immunodeficiency virus infection. Ophthal Plast Reconstr Surg 2005;21:314–315.
2. Ferry AP. Pyogenic granulomas of the eye and ocular adnexa: A study of 100 cases. Trans Am Ophthalmol Soc 1989;87:327–347.
3. Tseng SH. Conjunctival papilloma. Ophthalmology 2009;116:1013.
4. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol 2004;49:3–24.